美股新聞 標題聯播 · 近 24 小時 329 則 · 33 個來源 · 最新 9/20 03:38
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · TVTX近 30 天 6 則 · 第 1 / 1 頁
- Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Travere Therapeutics' Outlook Brightens As Turnaround Looms
- TGTX Stock Outperforms 95% of Stocks. Here's Why.
- IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'
- Three Biotech Stocks Stick Out With Their Stellar Charts
- Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline
- Travere Therapeutics (TVTX) Q2 2026 Earnings Call Transcript
- Why Travere Therapeutics (TVTX) Is Up 9.0% After FILSPARI-Driven Q2 Revenue Jump And Wider Loss
- Travere Therapeutics (TVTX) On Q2 Results And FILSPARI Hopes As Fair Value Stays In View
- This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
- Travere Therapeutics, Inc. Q2 2026 Earnings Call Summary
- Dow Jones Futures Rise But Techs Fall As Sandisk, Western Digital, Datadog Lead Earnings Losers
- Can Travere Therapeutics (TVTX) Be A Bargain After Its Q2 Surge?
- Travere Therapeutics to Participate at Upcoming Investor Conferences
- Travere Therapeutics Inc (TVTX) (Q2 2026) Earnings Call Highlights: Record FILSPARI Demand and ...
- Travere Therapeutics Q2 Earnings Call Highlights
- Travere (TVTX) Reports Q2 Earnings: What Key Metrics Have to Say
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。